April 26, 2024 Biodexa Pharmaceuticals PLC(“Biodexa” or the “Company”) Biodexa Enters Into Exclusive License to eRapa™, a Phase 3 Ready...
Not for distribution to United States news wire services or for dissemination in the United States TORONTO and HOUSTON, April 26, 2024...
Press release, Helsinki, 26 April 2024 at 3 PM (EEST) Neurosurgery Customer from Germany Orders Nexstim NBS System 5 Nexstim...
Press release, Helsinki, 26 April 2024 at 9 AM (EEST) Nexstim Plc Business Update Q1 2024 Nexstim Plc (NXTMH:HEX) (”Nexstim”...
In vitro studies with SNK01 have shown a direct ability to phagocytose and digest amyloid and alpha-synuclein proteins while also...
AUSTIN, Texas, April 25, 2024 /PRNewswire/ -- STEMREGEN®, the pioneer in stem cell science creating the most powerful supplements that...
SAN FRANCISCO, April 25, 2024 /PRNewswire/ -- Freedom Biosciences, Inc. ("Freedom Bio" or the "Company"), a clinical-stage biotechnology platform focused on...
TORONTO, ON / ACCESSWIRE / April 25, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way...
STOCKHOLM, SWEDEN / ACCESSWIRE / April 25, 2024 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO:ALZCUR) today announced...
Psirenity Health will be the Official "Wellness Partner" of Pickleball OntarioOakville, Ontario--(Newsfile Corp. - April 24, 2024) - Psirenity Health...
NEW YORK, NY / ACCESSWIRE / April 23, 2024 / Laxxon Medical, a leading 3D screen printing platform technology company,...
Researchers investigate how social bonds influence neural synchronization in the brain during joint coordination tasks Social interactions synchronize brain activity...
Relatient’s centralized scheduling platform and patient self-scheduling tools will enhance patient access while streamlining staff workflowsATLANTA--(BUSINESS WIRE)--#DashEngage--Anne Arundel Dermatology (AADerm),...
Data on the company’s portable MR imaging system show it can acquire brain images at the point of care that...
Conference call and webcast to begin at 1:30 p.m. PT (4:30 p.m. ET)IRVINE, Calif.--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) will release first...
Presentation on Monday, April 29th at 4:15 PM (GMT+1)HOUSTON, TX / ACCESSWIRE / April 23, 2024 / CNS Pharmaceuticals, Inc....
Nava Health in Columbia Increases Space as Local Demand Shows No Signs of Slowing COLUMBIA, MD / ACCESSWIRE / April...
Provides Further Evidence of Multiple Opportunities for Development of the FABP Inhibitor Platform in Cancer & Other Serious ConditionsSOLANA BEACH,...
Live video webcast with Chief Executive Officer, John Climaco, on Tuesday, April 23rd at 12:00 PM ETHOUSTON, TX / ACCESSWIRE...
TORONTO, ON / ACCESSWIRE / April 22, 2024 / FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), provides an update by way...